| Product NDC: | 17478-050 |
| Proprietary Name: | Sufenta |
| Non Proprietary Name: | sufentanil citrate |
| Active Ingredient(s): | 50 ug/mL & nbsp; sufentanil citrate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17478-050 |
| Labeler Name: | Akorn |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019050 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101201 |
| Package NDC: | 17478-050-01 |
| Package Description: | 10 AMPULE in 1 CARTON (17478-050-01) > 1 mL in 1 AMPULE |
| NDC Code | 17478-050-01 |
| Proprietary Name | Sufenta |
| Package Description | 10 AMPULE in 1 CARTON (17478-050-01) > 1 mL in 1 AMPULE |
| Product NDC | 17478-050 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sufentanil citrate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101201 |
| Marketing Category Name | NDA |
| Labeler Name | Akorn |
| Substance Name | SUFENTANIL CITRATE |
| Strength Number | 50 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |